Design of Pyrene-Fatty Acid Conjugates for Real-Time Monitoring of Drug Delivery and Controllability of Drug Release

Keita Hayashi, Yuma Mitsuyoshi, Toshiyuki Kamei, Toshinori Shimanouchi, Keishi Suga, Yukihiro Okamoto, Hidemi Nakamura, Hiroshi Umakoshi

Research output: Contribution to journalArticle

Abstract

Fluorescence probes are usually employed to analyze pharmacokinetics of drug carriers; however, this method using usual probes is not suitable to monitor drug carriers in detail because fluorescence spectra do not change by the disruption of drug carriers. In this study, pyrene-fatty acid conjugates were investigated as probes to monitor the state of drug carriers in real time. 1-Pyrenemethanol was conjugated with fatty acids, such as lauric acid, stearic acid, and behenic acid, and the conjugates were stirred in ethanol, resulting in the formation of submicron particles; these particles exhibited excimer emission. When J774.1 and Colon 26 cells were treated with these particles, the associated fluorescence spectra shifted from excimer emission to monomer emission. Moreover, the degree of change was controlled by the type of fatty acid. These results support the design of drug carriers that can be used to monitor pharmacokinetics in real time and to control the disruption time.

Original languageEnglish
Pages (from-to)3572-3580
Number of pages9
JournalACS Omega
Volume3
Issue number3
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Drug Carriers
Pyrene
Controllability
Drug delivery
Fatty acids
Pharmacokinetics
Fatty Acids
Fluorescence
Monitoring
lauric acid
Pharmaceutical Preparations
Stearic acid
Acids
Ethanol
Monomers
pyrene

ASJC Scopus subject areas

  • Chemistry(all)
  • Chemical Engineering(all)

Cite this

Design of Pyrene-Fatty Acid Conjugates for Real-Time Monitoring of Drug Delivery and Controllability of Drug Release. / Hayashi, Keita; Mitsuyoshi, Yuma; Kamei, Toshiyuki; Shimanouchi, Toshinori; Suga, Keishi; Okamoto, Yukihiro; Nakamura, Hidemi; Umakoshi, Hiroshi.

In: ACS Omega, Vol. 3, No. 3, 01.01.2018, p. 3572-3580.

Research output: Contribution to journalArticle

Hayashi, K, Mitsuyoshi, Y, Kamei, T, Shimanouchi, T, Suga, K, Okamoto, Y, Nakamura, H & Umakoshi, H 2018, 'Design of Pyrene-Fatty Acid Conjugates for Real-Time Monitoring of Drug Delivery and Controllability of Drug Release', ACS Omega, vol. 3, no. 3, pp. 3572-3580. https://doi.org/10.1021/acsomega.7b02061
Hayashi, Keita ; Mitsuyoshi, Yuma ; Kamei, Toshiyuki ; Shimanouchi, Toshinori ; Suga, Keishi ; Okamoto, Yukihiro ; Nakamura, Hidemi ; Umakoshi, Hiroshi. / Design of Pyrene-Fatty Acid Conjugates for Real-Time Monitoring of Drug Delivery and Controllability of Drug Release. In: ACS Omega. 2018 ; Vol. 3, No. 3. pp. 3572-3580.
@article{a8b219302a7542488f821d15f88bf97c,
title = "Design of Pyrene-Fatty Acid Conjugates for Real-Time Monitoring of Drug Delivery and Controllability of Drug Release",
abstract = "Fluorescence probes are usually employed to analyze pharmacokinetics of drug carriers; however, this method using usual probes is not suitable to monitor drug carriers in detail because fluorescence spectra do not change by the disruption of drug carriers. In this study, pyrene-fatty acid conjugates were investigated as probes to monitor the state of drug carriers in real time. 1-Pyrenemethanol was conjugated with fatty acids, such as lauric acid, stearic acid, and behenic acid, and the conjugates were stirred in ethanol, resulting in the formation of submicron particles; these particles exhibited excimer emission. When J774.1 and Colon 26 cells were treated with these particles, the associated fluorescence spectra shifted from excimer emission to monomer emission. Moreover, the degree of change was controlled by the type of fatty acid. These results support the design of drug carriers that can be used to monitor pharmacokinetics in real time and to control the disruption time.",
author = "Keita Hayashi and Yuma Mitsuyoshi and Toshiyuki Kamei and Toshinori Shimanouchi and Keishi Suga and Yukihiro Okamoto and Hidemi Nakamura and Hiroshi Umakoshi",
year = "2018",
month = "1",
day = "1",
doi = "10.1021/acsomega.7b02061",
language = "English",
volume = "3",
pages = "3572--3580",
journal = "ACS Omega",
issn = "2470-1343",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Design of Pyrene-Fatty Acid Conjugates for Real-Time Monitoring of Drug Delivery and Controllability of Drug Release

AU - Hayashi, Keita

AU - Mitsuyoshi, Yuma

AU - Kamei, Toshiyuki

AU - Shimanouchi, Toshinori

AU - Suga, Keishi

AU - Okamoto, Yukihiro

AU - Nakamura, Hidemi

AU - Umakoshi, Hiroshi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Fluorescence probes are usually employed to analyze pharmacokinetics of drug carriers; however, this method using usual probes is not suitable to monitor drug carriers in detail because fluorescence spectra do not change by the disruption of drug carriers. In this study, pyrene-fatty acid conjugates were investigated as probes to monitor the state of drug carriers in real time. 1-Pyrenemethanol was conjugated with fatty acids, such as lauric acid, stearic acid, and behenic acid, and the conjugates were stirred in ethanol, resulting in the formation of submicron particles; these particles exhibited excimer emission. When J774.1 and Colon 26 cells were treated with these particles, the associated fluorescence spectra shifted from excimer emission to monomer emission. Moreover, the degree of change was controlled by the type of fatty acid. These results support the design of drug carriers that can be used to monitor pharmacokinetics in real time and to control the disruption time.

AB - Fluorescence probes are usually employed to analyze pharmacokinetics of drug carriers; however, this method using usual probes is not suitable to monitor drug carriers in detail because fluorescence spectra do not change by the disruption of drug carriers. In this study, pyrene-fatty acid conjugates were investigated as probes to monitor the state of drug carriers in real time. 1-Pyrenemethanol was conjugated with fatty acids, such as lauric acid, stearic acid, and behenic acid, and the conjugates were stirred in ethanol, resulting in the formation of submicron particles; these particles exhibited excimer emission. When J774.1 and Colon 26 cells were treated with these particles, the associated fluorescence spectra shifted from excimer emission to monomer emission. Moreover, the degree of change was controlled by the type of fatty acid. These results support the design of drug carriers that can be used to monitor pharmacokinetics in real time and to control the disruption time.

UR - http://www.scopus.com/inward/record.url?scp=85044836851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044836851&partnerID=8YFLogxK

U2 - 10.1021/acsomega.7b02061

DO - 10.1021/acsomega.7b02061

M3 - Article

AN - SCOPUS:85044836851

VL - 3

SP - 3572

EP - 3580

JO - ACS Omega

JF - ACS Omega

SN - 2470-1343

IS - 3

ER -